These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 53657)

  • 1. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
    Eleftheriou N; Thomas HC; Heathcote J; Sherlock S
    Lancet; 1975 Dec; 2(7946):1171-3. PubMed ID: 53657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases.
    Fujiyama S; Sagara K; Takano J; Iwaoka D; Deguchi T; Mizuno K; Ohtomo N
    Gastroenterol Jpn; 1979 Dec; 14(6):604-10. PubMed ID: 230994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The e antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers.
    Bonino F; Pinna G; Recchia S; Rizzetto M
    Ric Clin Lab; 1976; 6(3):251-7. PubMed ID: 1025647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers.
    Hess G; Nielsen JO; Arnold W; Büschenfelde KH
    Scand J Gastroenterol; 1977; 12(3):325-30. PubMed ID: 866995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
    Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
    Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior and clinical significance of the eAg/ anti-e system in carriers of HBsAg].
    Pastore G; Dentico P; Fera G; Angarano G; Schiraldi O
    Boll Ist Sieroter Milan; 1977 Sep; 56(4):333-8. PubMed ID: 911461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of a microsomal antigen and its antibody in human liver diseases.
    Penner E; Emejuaiwe SO; Milgrom F
    Int Arch Allergy Appl Immunol; 1979; 59(4):459-64. PubMed ID: 221426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of HBsAg and anti-HBs: two consecutive infections or a sign of advanced chronic liver disease?
    Heijtink RA; van Hattum J; Schalm SW; Masurel N
    J Med Virol; 1982; 10(2):83-90. PubMed ID: 6183398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Behaviour of e antigen and antibody during chronic active liver disease.
    Vogten AJ; Summerskill WH
    Lancet; 1976 Sep; 2(7985):577. PubMed ID: 60654
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunological diagnosis of HBsAg liver disease by combined screening for the e system in the serum and the HB core and surface antigens in liver biopsy samples.
    Bonino F; Ponzetto A; Veglio V; Bosio G; Zaffino MC; Rizzetto M
    Ric Clin Lab; 1977; 7(4):365-72. PubMed ID: 615332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection, by three techniques, of hepatitis B surface antigen (HBsAg) and determination of HBsAg and anti-HBs titres in patients with chronic liver disease.
    Chiaramonte M; Heathcote J; Crees M; Sherlock S
    Gut; 1977 Jan; 18(1):1-6. PubMed ID: 838398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Australia antigen. Review 5. Hepatitis B antigens and antibodies in liver diseases].
    Ohlen J; Richter J
    Fortschr Med; 1976 Oct; 94(29):1608-18. PubMed ID: 992534
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: e and anti-e.
    Lancet; 1975 Dec; 2(7946):1191-2. PubMed ID: 53665
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver disease among homosexual males.
    Ellis WR; Murray-Lyon IM; Coleman JC; Evans BA; Fluker JL; Bull J; Keeling PW; Simmons PD; Banatvala JE; Willcox JR; Thompson RP
    Lancet; 1979 Apr; 1(8122):903-5. PubMed ID: 86669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver disease and the e antigen in HBsAg carriers with chronic renal failure.
    Coughlin GP; Van Deth AG; Disney AP; Hay J; Wangel AG
    Gut; 1980 Feb; 21(2):118-22. PubMed ID: 7380332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.